@@Lee-1 I feel depressed and frustrated, science feels like a joke, it's been 40 years that hiv has ravaged people but until now science is still powerless. I'll probably kill myself before the disease progresses, really disappointed
To all out there, stay focus on your health, meaning eating exercising right, try not to stress your self out, let us all put good energy out there in the universe, and claim it, agt will get this cure, hopefully sooner than later, or agt working with another company for this hiv cure, these scientists are on the ball, mean while stay 💪 strong
@@gwgwhywy4934 it seems like they don't know implications about the deases,if they really know and have experience it before, they would have speed up the research
The trials are not something that can be sped up. We are working as hard as we can to find a cure for this disease but things like this take time as we have to follow government regulations.
@@AmericanGeneTechnologies the government is really bad to introduce experimental regulations on hiv that i think is not appropriate, because they just sit at the desk making regulations without knowing that their regulations are making it harder for people researchers and hiv patients.
Did everyone catch that???? The protocol for the public for PEP (Post Exposure Prophylactic) is a 28 day course but it is different in a medical setting in time to get the drugs and dosage taken. Also 10% chance of infection during an exposure incident.
So she turned HIV positive even on PEP for 28 days? She didn't mention that she actually took it for 28 days. Anyone knows that crucial information about her case?
Her current husband who was previously HIV+ did not take his medication on a routine basis. It is still U=U (Undetectable =Untransmittal), but individuals still need to adhere to taking their medications on a routine basis.
The independent Institutional Review Board overseeing the clinical trial approved the next step of the clinical trial: analytic treatment interruption. American Gene Technologies has begun withdrawing participants from their antiretroviral drugs, which will ultimately reveal whether they are cured of HIV, meaning they no longer need daily medication, and can’t develop AIDS or become re-infected with HIV. American Gene Technologies expects to reveal the results of the ATI by the end of this year (2022).
@@AmericanGeneTechnologies Thanks for the reply. Keep up the good work everyone is thinking of you guys and please keep us inform if not weekly but fortnightly on the study.
@@AmericanGeneTechnologies What is the possibility of American Gene Technologies and Excision BioTherapeutics (developers of EBT-101) combining their research into a possible AGT103-T + EBT-101 combined therapy, in the possibility of having a "sterilizing" cure of HIV? As of now AGT103-T & EBT-101 are both being independently demonstrated for their safety and effectiveness before possibility combing both therapies, which are completely different approaches as AGT103-T grants HIV resistance to the T cells that are responsible for hunting HIV, allowing them do their job and fight HIV, like you would for any other virus. This includes continuously fighting the viral reservoir. EBT-101, on the other hand, is a temporary pulse of CRISPR-associated gene expression that aims to cut out all HIV from the human genome, but since the CRISPR-associated genes cannot be continuously expressed, they need to cut of 100% of HIV proviruses during their expression window, otherwise HIV can just replicate and return. American Gene Technologies will need to see updated data from both therapies to know how well both of them work and whether or not an AGT103-T+EBT-101 combination therapy would be warranted. Both AGT103-T & EBT-101 are both in clinical trials, which usually takes between 2 and 5 years because each time a patient is infused, they are extensively monitored for side effects, efficiency and variations in their response to the therapy. In regards to AGT103-T, in theory AGT103-T could be given a dose preventively, as a vaccine, but it would be significantly harder to make due to the lack of HIV specific TCR enrichment that are seen in PLHIV. Also, T cells which do not encounter their target will naturally reduce in number, so it's possible that AGT103-T would not be permanent in people who do not have HIV. AGT103-T archives the same functional effects as delta 32 variant (CCR5Δ32), which some people are born with and when HIV tries to enter their cells, it can't grip onto the mutated CCR5 produced by these individuals. AGT103-T does deliver miRNA to prevent CCR5 from expressing on the cell surface, which makes cells resistant to HIV entry.
We need a cure!
❤️❤️❤️❤️❤️
@@Lee-1 no cure yet. hopefully sometime in the future.
@@Lee-1 there are already some types of cancers that are already curable though. Such as Melanoma, Prostate, ect.
@@Lee-1 I feel depressed and frustrated, science feels like a joke, it's been 40 years that hiv has ravaged people but until now science is still powerless. I'll probably kill myself before the disease progresses, really disappointed
We’re close
Imagine if there was a cure for this
To all out there, stay focus on your health, meaning eating exercising right, try not to stress your self out, let us all put good energy out there in the universe, and claim it, agt will get this cure, hopefully sooner than later, or agt working with another company for this hiv cure, these scientists are on the ball, mean while stay 💪 strong
I pray that she doesn't get cancer
Agt we are patiently waiting for the results, May we received a good result out of it ,. Amen
I always hope for good news to come. but hope is only hope if we continue to study science slowly and lazily like this
@@gwgwhywy4934 it seems like they don't know implications about the deases,if they really know and have experience it before, they would have speed up the research
The trials are not something that can be sped up. We are working as hard as we can to find a cure for this disease but things like this take time as we have to follow government regulations.
@@AmericanGeneTechnologies government regulations ! Like what? Whilest we are surffereng, when?
@@AmericanGeneTechnologies the government is really bad to introduce experimental regulations on hiv that i think is not appropriate, because they just sit at the desk making regulations without knowing that their regulations are making it harder for people researchers and hiv patients.
How did he get it
do we have any cure sir jeff
Did everyone catch that???? The protocol for the public for PEP (Post Exposure Prophylactic) is a 28 day course but it is different in a medical setting in time to get the drugs and dosage taken.
Also 10% chance of infection during an exposure incident.
Sir from India we are very helpless,,,
I liked this story, thanks for sharing
Glad you enjoyed it!
So she turned HIV positive even on PEP for 28 days? She didn't mention that she actually took it for 28 days. Anyone knows that crucial information about her case?
Her current husband who was previously HIV+ did not take his medication on a routine basis. It is still U=U (Undetectable =Untransmittal), but individuals still need to adhere to taking their medications on a routine basis.
No, she didn't know about PEP. She didn't take anything.
So amazing how love is so powerful.
mong các nhà khoa học các nước nghiên cứu trị khỏi hẳn hiv nhanh nhất có thể ạ
kB Nói chuyện đc ko bạn
When this medicine/vaccine come in market.
@@SagarKumar-vj8hp hi bro
@@SagarKumar-vj8hp u from bro? R u hiv positive?
Ye Puri trah cure ho gya hai ki avi trial ho raha h please zalur btana please 🙏
Eat healthy!!! Love, don’t stress,
Any updates on the human trials or has that all fallen apart now??
The independent Institutional Review Board overseeing the clinical trial approved the next step of the clinical trial: analytic treatment interruption. American Gene Technologies has begun withdrawing participants from their antiretroviral drugs, which will ultimately reveal whether they are cured of HIV, meaning they no longer need daily medication, and can’t develop AIDS or become re-infected with HIV. American Gene Technologies expects to reveal the results of the ATI by the end of this year (2022).
@@AmericanGeneTechnologies Thanks for the reply. Keep up the good work everyone is thinking of you guys and please keep us inform if not weekly but fortnightly on the study.
What do we have to say? we have nothing to say all that we can say is hmm we are still waiting for good news to reveal
@@matharasantewaa586....sorry to ask asantewaa re u hiv+
@@AmericanGeneTechnologies
What is the possibility of American Gene Technologies and Excision BioTherapeutics (developers of EBT-101) combining their research into a possible AGT103-T + EBT-101 combined therapy, in the possibility of having a "sterilizing" cure of HIV?
As of now AGT103-T & EBT-101 are both being independently demonstrated for their safety and effectiveness before possibility combing both therapies, which are completely different approaches as AGT103-T grants HIV resistance to the T cells that are responsible for hunting HIV, allowing them do their job and fight HIV, like you would for any other virus. This includes continuously fighting the viral reservoir.
EBT-101, on the other hand, is a temporary pulse of CRISPR-associated gene expression that aims to cut out all HIV from the human genome, but since the CRISPR-associated genes cannot be continuously expressed, they need to cut of 100% of HIV proviruses during their expression window, otherwise HIV can just replicate and return. American Gene Technologies will need to see updated data from both therapies to know how well both of them work and whether or not an AGT103-T+EBT-101 combination therapy would be warranted.
Both AGT103-T & EBT-101 are both in clinical trials, which usually takes between 2 and 5 years because each time a patient is infused, they are extensively monitored for side effects, efficiency and variations in their response to the therapy.
In regards to AGT103-T, in theory AGT103-T could be given a dose preventively, as a vaccine, but it would be significantly harder to make due to the lack of HIV specific TCR enrichment that are seen in PLHIV. Also, T cells which do not encounter their target will naturally reduce in number, so it's possible that AGT103-T would not be permanent in people who do not have HIV.
AGT103-T archives the same functional effects as delta 32 variant (CCR5Δ32), which some people are born with and when HIV tries to enter their cells, it can't grip onto the mutated CCR5 produced by these individuals. AGT103-T does deliver miRNA to prevent CCR5 from expressing on the cell surface, which makes cells resistant to HIV entry.
So no word on the human trials
Supposed to be efficacy results of the volunteers who stopped their meds this month.
Sir please please help me india 🙏🙏🙏🙏🙏🙏🙏🙏🙏🙏🙏🙏🙏
What's type need?
@@ROYALSHADOW-v7jcuring for HIV 🙏🙏🙏🙏🙏😭😭
@@gopidheena2969 Naval aids research centre, check kar sakta hai mobile par
Si una cura se necesta
👍👍👍👍👍👍👍👍